Explore more publications!
Laayoune Tech Observer
Got News to Share?

Laayoune Tech Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laayoune Tech Observer.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 
December 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 

Indeterminate GlobeNewswire
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
December 17, 2025

Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer

Indeterminate GlobeNewswire
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
December 17, 2025

Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil

Indeterminate GlobeNewswire
Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap® 150 Rollout
December 17, 2025

Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap® 150 Rollout

Indeterminate GlobeNewswire
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
December 17, 2025

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates

Indeterminate GlobeNewswire
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
December 17, 2025

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Indeterminate GlobeNewswire
Xeronum Emerges to Power the Next Wave of Digital Experiences
December 17, 2025

Xeronum Emerges to Power the Next Wave of Digital Experiences

Indeterminate GlobeNewswire
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
December 17, 2025

Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

Indeterminate GlobeNewswire
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
December 17, 2025

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets

Indeterminate GlobeNewswire
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
December 17, 2025

Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers

Indeterminate GlobeNewswire
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
December 17, 2025

Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma

Indeterminate GlobeNewswire
Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases
December 17, 2025

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

Indeterminate GlobeNewswire
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome
December 17, 2025

Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome

Indeterminate GlobeNewswire
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
December 17, 2025

Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program

Indeterminate GlobeNewswire
Coder and GlobalLogic Partner to Accelerate AI Development in the Enterprise
December 17, 2025

Coder and GlobalLogic Partner to Accelerate AI Development in the Enterprise

Indeterminate GlobeNewswire
ONAR Holding Newly Acquired ‘JUICE’ Marketing Team, Achieves Record Black Friday Results on All Metrics, Exceeds Volume Targets By 300%+
December 17, 2025

ONAR Holding Newly Acquired ‘JUICE’ Marketing Team, Achieves Record Black Friday Results on All Metrics, Exceeds Volume Targets By 300%+

Indeterminate GlobeNewswire
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 
December 17, 2025

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions